Hannah H. Chiu

Hannah H. Chiu

Auto-generated profile, based on publicly available information

Hannah H. Chiu

Uptown Eye Specialists, Vaughan, Ontario, Canada

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in Canadian Journal of Ophthalmology
Verified
Journal Article
Closed access
HCHannah Chiu
Hannah Chiu
HDHarry Dang
Harry Dang
CCCrystal Cheung
Crystal Cheung
DKDeepak Khosla
Deepak Khosla
PAParnian Arjmand
Parnian Arjmand
LDLarissa Derzko-Dzulynsky
Larissa Derzko-Dzulynsky

1 June 2022 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
MLMark K Lukewich
Mark K Lukewich
FMFahmeeda Murtaza
Fahmeeda Murtaza
SSSohel Somani
Sohel Somani
ETEric S Tam
Eric S Tam
HCHannah H Chiu
Hannah H Chiu
Aim: To compare residual astigmatism prediction errors across Barrett toric calculations using predicted posterior corneal astigmatism (PCA) and PCA measured using the IOL Master 700 with total keratometry (IOLM). Methods: A retrospective cohort study was undertaken on patients with corneal astigmatism and no other ocular comorbidities that underwent uneventful refractive femtosecond laser-assisted cataract surgery with toric IOL implantation between May 2019 and November 2019. Toric calculations were performed using the Barrett toric calculator and the following values: predicted PCA with anterior corneal measurements from Pentacam, IOLM standard keratometry (SK), OPD scan, and median measurements from these devices; predicted PCA with IOLM total keratometry (TK); and measured PCA with IOLM SK or IOLM TK. Residual astigmatism prediction error was calculated for each device and method of calculation at postoperative month 1 and 3 using the astigmatism double angle plot tool. Results: A total of 24 eyes, 10 with-the-rule (WTR), 10 against-the-rule (ATR) and 4 oblique astigmatism, from 24 patients were included in this study. PCA ranged from 0.00 to 0.67 D with a mean of 0.24 ± 0.15 D in all eyes. PCA was significantly greater in WTR eyes (0.32 D) compared to ATR eyes (0.16 D; p < 0.05). In ATR eyes, calculations made using IOLM SK and measured PCA had significantly lower total corneal astigmatism and toric IOL cylinder power compared to calculations made using Pentacam and IOLM TK (p < 0.05). No significant difference in mean absolute or centroid residual astigmatism prediction error was observed across devices or calculation methods. The percentage of eyes with absolute astigmatism prediction errors ≤ 0.5 D was not significantly different across groups. Conclusion: Barrett toric calculations using predicted PCA and PCA measured using IOLM produced comparable residual astigmatism prediction errors. The incorporation of median measurements did not significantly impact calculation accuracy.

1 July 2022 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
FMFahmeeda Murtaza
Fahmeeda Murtaza
DTDana Toameh
Dana Toameh
HCHannah H Chiu
Hannah H Chiu
ETEric S Tam
Eric S Tam
SSSohel Somani
Sohel Somani
Purpose: To evaluate the effects of autologous platelet‐rich plasma (PRP) drops for evaporative dry eye (EDE) disease from meibomian gland dysfunction (MGD). Methods: This is a retrospective, consecutive case series of 20 eyes of 10 patients with EDE from MGD treated with PRP drops from November 2020 to November 2021 at a single outpatient clinic in Ontario, Canada. PRP drops were prepared from whole blood using a two-step centrifugation method. Patients were instructed to instill these drops six times daily for 4 weeks. The Canadian Dry Eye Assessment (CDEA) questionnaire score, patient subjective assessment (PSA) score, first and average non-invasive break-up times (f/a NIBUT), tear meniscus height (TMH), bulbar redness (BR), and meibograph grade (MG) were measured before and after the treatment course. Results: Significant improvements in dry eye symptoms and tear film parameters were observed. Dry eye symptoms significantly improved as per the CDEA (mean difference (MD) = − 5.45, 95% confidence interval (CI) = [− 7.9, − 3.1], p< 0.001) and PSA (MD = − 2.6, 95% CI = [− 3.9, − 1.2], p< 0.001). There were significant improvements in tear film parameters including fNIBUT (MD = 3.85s, 95% CI = [1.2, 6.8], p=0.006), aNIBUT (MD = − 6.81s, 95% CI = [5.7, 11.1], p< 0.001) and TMH (MD = 0.08, 95% CI = [0.003, 0.2], p=0.045). There was an improvement in conjunctival injection as measured by BR (MD = − 0.36, 95% CI = [− 0.4, − 0.15], p=0.373). Five eyes experienced a one-grade improvement in MG (p=0.453), and none experienced worsening in MG with treatment. No temporary or permanent adverse effects were noted. Conclusion: Four weeks of PRP therapy resulted in significant functional improvements in dry eye symptoms and tear film quality and quantity. Improvements in conjunctival injection and microstructural improvements in meibomian glands were also observed in some eyes. Overall, PRP is a promising treatment option for patients with EDE from MGD refractory to conventional treatments.

14 April 2023 in Canadian Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
MCMilena Cioana
Milena Cioana
RGRishi B. Gupta
Rishi B. Gupta
ETEric S. Tam
Eric S. Tam
HCHannah H. Chiu
Hannah H. Chiu
IGIleana Gold
Ileana Gold
SSSohel Somani
Sohel Somani

1 February 2024 in Journal of Cataract & Refractive Surgery
Verified
Journal Article
Closed access
MCMilena Bhsc Cioana
Milena Bhsc Cioana
YPYogesh Md Frcsc Patodia
Yogesh Md Frcsc Patodia
LTLili Md Frcsc Tong
Lili Md Frcsc Tong
HCHannah H. Md Frcsc Chiu
Hannah H. Md Frcsc Chiu
ETEric S. Md Frcsc Tam
Eric S. Md Frcsc Tam
SSSohel Md Frcsc Somani
Sohel Md Frcsc Somani
Purpose: To evaluate the effect of femtosecond laser-assisted cataract surgery (FLACS) and manual cataract surgery (MCS) on proinflammatory cytokine expression in patients with diabetes vs nondiabetic patients. Setting: Outpatient surgical center in Vaughan, Ontario, Canada. Design: Prospective cohort study. Methods: Patients with diabetes and nondiabetic patients undergoing noncomplicated MCS or FLACS were assigned into 4 cohorts: MCS nondiabetic (n = 30), FLACS nondiabetic (n = 42), MCS diabetic (n = 40), and FLACS diabetic (n = 40). Aqueous humor inflammatory mediator concentrations were evaluated at MCS onset and after femtosecond laser treatment. The presence of cystoid macular edema, anterior chamber (AC) inflammation, central retinal thickness, macular volume, and retinal microvascular changes (through optical coherence tomography angiography) were evaluated preoperatively and on postoperative day 1, week 1, month 1 (POM1), and month 3 (POM3). Results: Patients with diabetes receiving FLACS had a higher concentration of interleukin (IL)-7, IL-13, and interferon-induced protein-10 than MCS diabetic patients; they also demonstrated higher levels of vascular endothelial growth factor and lower levels of interferon (IFN)-γ, granulocyte colony-stimulating factor, and IFN-α2 compared with MCS nondiabetic patients. Macular volume appeared to be significantly higher in MCS diabetic vs MCS non-diabetic patients at POM1 and between FLACS diabetic vs FLACS nondiabetic patients at POM3. There were no other significant differences between the cohorts for any parameter. Conclusions: FLACS use in patients with diabetes demonstrated some differences in AC cytokine expression compared with non-diabetic FLACS or diabetic patients undergoing MCS; however, there was no increase in clinical inflammatory biomarkers. FLACS seems to be a safe technique to use in patients with diabetes.

6 September 2024 in Canadian Journal of Ophthalmology
Verified
Journal Article
Closed access
SKSaffire H. Krance
Saffire H. Krance
AHAmin Hatamnejad
Amin Hatamnejad
RURutmila Uddin
Rutmila Uddin
SSSohel Somani
Sohel Somani
ETEric Tam
Eric Tam
HCHannah H. Chiu
Hannah H. Chiu